Zerbaxa 1 g/0,5 g Pulver für ein Konzentrat zur Herstellung einer Infusionslösung

Recall | Medicines | 18/12/2020

The marketing authorization holder informed its customers on December 17, 2020 that due to potential microbiological contamination the listed batches are recalled as a precautionary measure.

Name of the medicinal product Zerbaxa 1 g/0,5 g Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Marketing authorisation number(s) EU/1/15/1032/001
CIP code 4225279
Marketing authorisation holder Merck Sharp & Dohme B.V.
Batch number(s) Batch, Expiry Date
S040223, 12.2021
S041248, 12.2021
T003814, 12.2021
T004275, 02.2022
T008945, 02.2022
T025193, 06.2022
Classification of the recall 2
Depth of recall Pharmacies
BASG reference number INS-640.001-3389